November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Gregory Riely: Updated NCCN guidelines for treatment of patients with thymoma and thymic carcinoma
Nov 2, 2024, 19:57

Gregory Riely: Updated NCCN guidelines for treatment of patients with thymoma and thymic carcinoma

Gregory Riely, Medical oncologist at Memorial Sloan Kettering Cancer Center, shared on X:

“Updated NCCN guidelines for treatment of patients with thymoma and thymic carcinoma were released.

For thymic carcinoma, there are some new additions for treatment options in both first line and second line.

For first line treatment of thymic carcinoma, the regimen of carboplatin, paclitaxel, and ramucirumab was added, based on RELEVENT trial with response rate of 58% and median PFS was 18.1 months.

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

Authors: C Proto, M Ganzinelli, S Manglaviti, M Imbimbo, G Galli, M Marabese, F Zollo, M F Alvisi, M Perrino, N Cordua, F Borea, F de Vincenzo, A Chella, S Cappelli, E Pardini, Z Ballatore, A Lucarelli, E Ambrosini, M Giuliano, E Pietroluongo, C Mulargiu, A Fabbri, A Prelaj, M Occhipinti, M Brambilla, L Mazzeo, T Beninato, R Vigorito, M Ruggirello, F G Greco, G Calareso, D Miliziano, E Rulli, I De Simone, V Torri, F G M de Braud, G Pasello, P De Placido, R Berardi, I Petrini, P Zucali, M C Garassino, G Lo Russo

Gregory Riely

In subsequent therapy for thymic carcinoma, regimen of avelumab + axitinib was added (CAVEATT), 34% response rate and median PFS of 8 months for combination. As in other ICI trials in thymic carcinoma, high rates of polymyositis and other immune related AE.”

Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial

Authors: Fabio Conforti, Paolo Andrea Zucali, Laura Pala, Chiara Catani, Vincenzo Bagnardi, Isabella Sala, Paolo Della Vigna, Matteo Perrino, Paola Zagami, Chiara Corti, Sara Stucchi, Massimo Barberis, Elena Guerini-Rocco, Benedetta Di Venosa, Fabio De Vincenzo, Nadia Cordua, Armando Santoro, Giuseppe Giaccone, Tommaso Martino De Pas

Gregory Riely